These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10753262)

  • 1. Tyrosine hydroxylase deficiency with severe clinical course: clinical and biochemical investigations and optimization of therapy.
    Dionisi-Vici C; Hoffmann GF; Leuzzi V; Hoffken H; Bräutigam C; Rizzo C; Steebergen-Spanjers GC; Smeitink JA; Wevers RA
    J Pediatr; 2000 Apr; 136(4):560-2. PubMed ID: 10753262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked improvement in Segawa syndrome after L-dopa and selegiline treatment.
    Yosunkaya E; Karaca E; Basaran S; Seven M; Yüksel A
    Pediatr Neurol; 2010 May; 42(5):348-50. PubMed ID: 20399390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tyrosine hydroxylase deficiency: a case of autosomal recessive dopa-responsive dystonia].
    Tan D; Zhang Y; Ye J; Han L; Qiu W; Gu X; Zhang H
    Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):616-9. PubMed ID: 25224241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency.
    Pons R; Syrengelas D; Youroukos S; Orfanou I; Dinopoulos A; Cormand B; Ormazabal A; Garzía-Cazorla A; Serrano M; Artuch R
    Mov Disord; 2013 Jul; 28(8):1058-63. PubMed ID: 23389938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimization of the treatment of Parkinson's disease using dopamine agonists].
    Rinne UK
    Arch Neurobiol (Madr); 1991; 54(6):282-7. PubMed ID: 1687430
    [No Abstract]   [Full Text] [Related]  

  • 6. Expanding phenotype and clinical analysis of tyrosine hydroxylase deficiency.
    Yeung WL; Wong VC; Chan KY; Hui J; Fung CW; Yau E; Ko CH; Lam CW; Mak CM; Siu S; Low L
    J Child Neurol; 2011 Feb; 26(2):179-87. PubMed ID: 20823027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid synaptic proteins as useful biomarkers in tyrosine hydroxylase deficiency.
    Ortez C; Duarte ST; Ormazábal A; Serrano M; Pérez A; Pons R; Pineda M; Yapici Z; Fernández-Álvarez E; Domingo-Jiménez R; De Castro P; Artuch R; García-Cazorla A
    Mol Genet Metab; 2015 Jan; 114(1):34-40. PubMed ID: 25468651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.
    Willemsen MA; Verbeek MM; Kamsteeg EJ; de Rijk-van Andel JF; Aeby A; Blau N; Burlina A; Donati MA; Geurtz B; Grattan-Smith PJ; Haeussler M; Hoffmann GF; Jung H; de Klerk JB; van der Knaap MS; Kok F; Leuzzi V; de Lonlay P; Megarbane A; Monaghan H; Renier WO; Rondot P; Ryan MM; Seeger J; Smeitink JA; Steenbergen-Spanjers GC; Wassmer E; Weschke B; Wijburg FA; Wilcken B; Zafeiriou DI; Wevers RA
    Brain; 2010 Jun; 133(Pt 6):1810-22. PubMed ID: 20430833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical hallmarks of tyrosine hydroxylase deficiency.
    Bräutigam C; Wevers RA; Jansen RJ; Smeitink JA; de Rijk-van Andel JF; Gabreëls FJ; Hoffmann GF
    Clin Chem; 1998 Sep; 44(9):1897-904. PubMed ID: 9732974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine hydroxylase deficiency with severe clinical course.
    Zafeiriou DI; Willemsen MA; Verbeek MM; Vargiami E; Ververi A; Wevers R
    Mol Genet Metab; 2009 May; 97(1):18-20. PubMed ID: 19282209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-dopa and selegiline for tyrosine hydroxylase deficiency.
    Häussler M; Hoffmann GF; Wevers RA
    J Pediatr; 2001 Mar; 138(3):451-2. PubMed ID: 11241071
    [No Abstract]   [Full Text] [Related]  

  • 12. Sepiapterin reductase deficiency: clinical presentation and evaluation of long-term therapy.
    Echenne B; Roubertie A; Assmann B; Lutz T; Penzien JM; Thöny B; Blau N; Hoffmann GF
    Pediatr Neurol; 2006 Nov; 35(5):308-13. PubMed ID: 17074599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of biogenic amines affecting the metabolism of serotonin and catecholamines.
    Lamers KJ; Wevers RA
    Mult Scler; 1998 Feb; 4(1):37-8. PubMed ID: 9532591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine hydroxylase deficiency unresponsive to L-dopa treatment with unusual clinical and biochemical presentation.
    DE Lonlay P; Nassogne MC; van Gennip AH; van Cruchten AC; Billatte de Villemeur T; Cretz M; Stoll C; Launay JM; Steenberger-Spante GC; van den Heuvel LP; Wevers RA; Saudubray JM; Abeling NG
    J Inherit Metab Dis; 2000 Dec; 23(8):819-25. PubMed ID: 11196107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term course of L-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency.
    Schiller A; Wevers RA; Steenbergen GC; Blau N; Jung HH
    Neurology; 2004 Oct; 63(8):1524-6. PubMed ID: 15505183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine hydroxylase deficiency in Taiwanese infants.
    Chi CS; Lee HF; Tsai CR
    Pediatr Neurol; 2012 Feb; 46(2):77-82. PubMed ID: 22264700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine hydroxylase deficiency presenting with a biphasic clinical course.
    Giovanniello T; Leuzzi V; Carducci C; Carducci C; Sabato ML; Artiola C; Santagata S; Pozzessere S; Antonozzi I
    Neuropediatrics; 2007 Aug; 38(4):213-5. PubMed ID: 18058633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia.
    Hoffmann GF; Assmann B; Bräutigam C; Dionisi-Vici C; Häussler M; de Klerk JB; Naumann M; Steenbergen-Spanjers GC; Strassburg HM; Wevers RA
    Ann Neurol; 2003; 54 Suppl 6():S56-65. PubMed ID: 12891655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies in the treatment of early Parkinson's disease.
    Rinne UK
    Acta Neurol Scand Suppl; 1993; 146():50-3. PubMed ID: 8101417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatic L-amino acid decarboxylase deficiency with hyperdopaminuria. Clinical and laboratory findings in response to different therapies.
    Fiumara A; Bräutigam C; Hyland K; Sharma R; Lagae L; Stoltenborg B; Hoffmann GF; Jaeken J; Wevers RA
    Neuropediatrics; 2002 Aug; 33(4):203-8. PubMed ID: 12368991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.